Call Us: +44 (0) 1752 753723[email protected]


Harvard Stem Cell Institute publishes the results of its clinical trial that could increase the success rates of umbilical cord blood transplants by identifying a molecule derived from fatty acids. Stem  cell transplants usually require stringent blood type matching which can often hinder the patient’s ability to find a donor. Umbilical cord transplants  improve flexibility and safety as it does not need to be exactly matched and has had less exposure to viruses. The identification of the molecule could help 50-60 percent of patients who do not have siblings with a matching blood type. For more information read here